Towards Risk Stratification in Clinical Care for IgA Nephropathy: Genetic Risk Scores: Comments on the Study "Clinical Application of Polygenic Risk Score in IgA Nephropathy"
- PMID: 39723228
- PMCID: PMC11666848
- DOI: 10.1007/s43657-024-00184-8
Towards Risk Stratification in Clinical Care for IgA Nephropathy: Genetic Risk Scores: Comments on the Study "Clinical Application of Polygenic Risk Score in IgA Nephropathy"
Conflict of interest statement
Conflict of InterestOn behalf of all authors, the corresponding author states that there is no conflict of interest.
Similar articles
-
Clinical use of polygenic scores in type 2 diabetes: challenges and possibilities.Diabetologia. 2025 Jul;68(7):1361-1374. doi: 10.1007/s00125-025-06419-1. Epub 2025 Apr 5. Diabetologia. 2025. PMID: 40186687 Free PMC article. Review.
-
Machine-learning model based on ultrasomics for non-invasive evaluation of fibrosis in IgA nephropathy.Eur Radiol. 2025 Jul;35(7):3707-3720. doi: 10.1007/s00330-025-11368-9. Epub 2025 Jan 24. Eur Radiol. 2025. PMID: 39853332
-
Potential benefits and related treatment effects of calcineurin inhibitors combined with steroid for IgA nephropathy: a systematic review and meta-analysis.Int Urol Nephrol. 2023 Sep;55(9):2227-2236. doi: 10.1007/s11255-023-03524-1. Epub 2023 Mar 1. Int Urol Nephrol. 2023. PMID: 36856924
-
Efficacy and safety of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for IgA nephropathy in children.Pediatr Nephrol. 2022 Mar;37(3):499-508. doi: 10.1007/s00467-021-05316-0. Epub 2021 Oct 22. Pediatr Nephrol. 2022. PMID: 34686915
-
Global glomerulosclerosis proportions predict nephropathy progression in IgA nephropathy: a multicenter retrospective analysis with propensity score matching.Ren Fail. 2025 Dec;47(1):2486567. doi: 10.1080/0886022X.2025.2486567. Epub 2025 May 5. Ren Fail. 2025. PMID: 40325551 Free PMC article.
References
-
- Barbour SJ, Canney M, Coppo R et al (2020) Improving treatment decisions using personalized risk assessment from the international IgA nephropathy prediction tool. Kidney Int 98(4):1009–1019. 10.1016/j.kint.2020.04.042 - PubMed
-
- Barbour SJ, Coppo R, Zhang H et al (2022) Application of the international IgA nephropathy prediction tool one- or two-years post-biopsy. Kidney Int 102(1):160–172. 10.1016/j.kint.2022.02.042 - PubMed
LinkOut - more resources
Miscellaneous